Purpose
For patients with local recurrent disease after radical prostatectomy (35–54%) salvage radiotherapy (SRT) is the treatment of choice.
Materials and methods
Patients with biochemically recurrent prostate cancer after radical prostatectomy, who were treated with SRT (3D-CRT) at our institution between 1998 and 2012, were included in this retrospective cohort analysis. Primary endpoint was urinary incontinence rate.
Results
244 patients were included. Median follow-up after SRT was 50 months (range: 4–187 months).
Before start of SRT 69.7% of patients were continent for urine.
After SRT de novo urinary incontinence complaints (grade ≥ 1 - Spontaneous flow; Pads indicated) occurred in the respective acute ( 90 days) in 6.1% and 17.6% of patients.
The respective 5-year bPFS, OS, DSS and DMFS rates were
47.6%, Biochemical Free Survival rate
91.8% Overall Survival Rate
98.8% Disease Specific Survival rate and
80.5% Distant Metastisis Free Survival rate.
